HT
EGRX

HAP Trading’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

HAP Trading’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-33,600
Closed -$13K – 1749
2022
Q4 		$13K Sell
33,600
-5,200
-13% -$165K ﹤0.01% 1069
2022
Q3 		$12K Buy
+38,800
New +$1.42M ﹤0.01% 1292
2017
Q3 		– Sell
-10,900
Closed -$44K – 1118
2017
Q2 		$44K Buy
+10,900
New +$891K ﹤0.01% 703
2016
Q4 		– Sell
-11,100
Closed -$122K – 1266
2016
Q3 		$122K Sell
11,100
-53,700
-83% -$2.98M ﹤0.01% 569
2016
Q2 		$35K Buy
+64,800
New +$2.7M ﹤0.01% 660

Other funds holding EGRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return